Search - tctmd.com

Displaying 161 - 180 of 206

Sort: Relevancy | Date

News Daily News

Bempedoic Acid Safe, Lowers LDL in Hypercholesterolemia: Pooled RCT Data

Yael L. Maxwell

July 07, 2020

News Daily News

Multiorgan Clotting in COVID-19 Hints at Platelets’ Role in Inflammatory Response

L.A. McKeown

June 25, 2020

News Daily News

Azithromycin Again Linked to Higher CV Mortality Risk

Caitlin E. Cox

June 23, 2020

News Daily News

Hydroxychloroquine Fails to Prevent COVID-19 in Those Exposed to the Virus: RCT

Caitlin E. Cox

June 05, 2020

News Daily News

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Yael L. Maxwell

May 28, 2020

News Daily News

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

Yael L. Maxwell

May 21, 2020

News Daily News HRS 2020

‘Silent’ Brain Infarcts Common, Tied to Cognitive Decline in A-fib

Todd Neale

May 14, 2020

News Features

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

Michael O'Riordan

May 12, 2020

News Features

Stroke ‘Surge’ in the Young Fuels Debate Over COVID-19’s Culpability

Todd Neale

May 08, 2020

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

News Daily News

Remdesivir Study for COVID-19 Yields Positive Top-line Results

Michael O'Riordan

April 29, 2020

News Daily News

Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus

Michael O'Riordan

April 29, 2020

News Features

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

Michael O'Riordan

April 24, 2020

News Daily News

ACE Inhibitors/ARBs Safe, Possibly Protective in Hypertensive COVID-19 Patients

Caitlin E. Cox

April 24, 2020

News Daily News

COVID-19 Drug Candidates May Raise Arrhythmia Risk

Caitlin E. Cox

April 03, 2020

News Conference News ACC 2020

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

L.A. McKeown

April 02, 2020

News Conference News ACC 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

Todd Neale

April 02, 2020

News Conference News ACC 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Michael O'Riordan

April 02, 2020

News Conference News ACC 2020

Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients

L.A. McKeown

April 01, 2020

Hope for these hard-to-treat patients: more than half saw ≥ 50% decrease at 24 weeks, regardless of LDL receptor function.

News Conference News ACC 2020

Evinacumab Cuts LDL Cholesterol in Homozygous FH

Yael L. Maxwell

April 01, 2020

Advertisement

Bempedoic Acid Safe, Lowers LDL in Hypercholesterolemia: Pooled RCT Data

Multiorgan Clotting in COVID-19 Hints at Platelets’ Role in Inflammatory Response

Azithromycin Again Linked to Higher CV Mortality Risk

Hydroxychloroquine Fails to Prevent COVID-19 in Those Exposed to the Virus: RCT

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

‘Silent’ Brain Infarcts Common, Tied to Cognitive Decline in A-fib

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

Stroke ‘Surge’ in the Young Fuels Debate Over COVID-19’s Culpability

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Remdesivir Study for COVID-19 Yields Positive Top-line Results

Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus

COVID-19 Lockdown Inactivity May Spell Trouble for CVD Prevention

ACE Inhibitors/ARBs Safe, Possibly Protective in Hypertensive COVID-19 Patients

COVID-19 Drug Candidates May Raise Arrhythmia Risk

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients

Evinacumab Cuts LDL Cholesterol in Homozygous FH

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content